Abstract
Purpose
Isoflurane (ISO) is the most commonly used preclinical inhalation anesthetic. This is a problem in 19F MRI of fluorine contrast agents, as ISO signals cause artifacts that interfere with unambiguous image interpretation and quantification; the two most attractive properties of heteronuclear MRI. We aimed to avoid these artifacts using MRI strategies that can be applied by any pre-clinical researcher.
Procedures
Three strategies to avoid ISO chemical shift displacement artifacts (CSDA) in 19F MRI are described and demonstrated with measurements of 19F-containing agents in phantoms and in vivo (n = 3 for all strategies). The success of these strategies is compared to a standard Rapid Acquisition with Relaxation Enhancement (RARE) sequence, with phantom and in vivo validation. ISO artifacts can successfully be avoided by (1) shifting them outside the region of interest using a narrow signal acquisition bandwidth, (2) suppression of ISO by planning a frequency-selective suppression pulse before signal acquisition or by (3) preventing ISO excitation with a 3D sequence with a narrow excitation bandwidth.
Results
All three strategies result in complete ISO signal avoidance (p < 0.0001 for all methods). Using a narrow acquisition bandwidth can result in loss of signal to noise ratio and distortion of the image, and a frequency-selective suppression pulse can be incomplete when B1-inhomogeneities are present. Preventing ISO excitation with a narrow excitation pulse in a 3D sequence yields the most robust results (relative SNR 151 ± 28% compared to 2D multislice methods, p = 0.006).
Conclusion
We optimized three easily implementable methods to avoid ISO signal artifacts and validated their performance in phantoms and in vivo. We make recommendation on the parameters that pre-clinical studies should report in their method section to make the used approach insightful.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Molecules with incorporated Fluorine-19 (19F) receive much interest as Magnetic Resonance Imaging (MRI) contrast agents in heteronuclear or hot-spot imaging [1,2,3]. With 19F MRI, background-free in vivo images can be acquired, which can be combined with conventional proton MRI for precise anatomical localization. Moreover, the 19F signal is unambiguous; the signal measured is linear to the concentration of the imaging agent [4], and allows for quantification from the image data [5]. This differentiates heteronuclear contrast agents from conventional contrast agents, such as gadolinium chelates and super paramagnetic iron oxide particles, which create contrast by altering the existing signal [6, 7]. 19F MRI does suffer from sensitivity issues, limited number of clinically approved imaging agents and the need for dedicated hardware. Currently, 19F MRI has been successfully implemented in preclinical studies in which it is used for cell tracking and inflammation imaging [8,9,10,11,12]. Simultaneously, clinical hurdles are being overcome with the first in-human studies and good manufacturing process-certified production methods [13, 14].
In nearly all preclinical studies, the animals need to be anesthetized during imaging to prevent unwanted movement and discomfort. This is most frequently done with isoflurane (ISO) inhalation anesthesia. As the name implies, ISO is a fluorinated anesthetic agent and at therapeutic levels its concentration is sufficient to be observed in MRI [15]. Therefore, the fluorine atoms in ISO are a problem for 19F MRI as conventional MRI-sequences cannot distinguish ISO from the fluorinated contrast agent leading to artifacts in imaging. The ISO artifact signal can lead to misinterpretation of the images. Furthermore, when imaging agent and ISO signals overlap, quantification is no longer accurate.
The simplest way of avoiding ISO artifacts in 19F MRI is to use a different anesthetic agent without fluorine atoms (e.g. ketamine, pentobarbital). However, ISO is very easy to use, widely available and has relatively little influence on cardiovascular function and cerebrovascular blood flow [16, 17]. Therefore, ISO is preferred above all other anesthetic agents, even in 19F MRI applications.
To be able to use ISO in 19F MRI applications, we present three methods that can be used to avoid imaging artifacts from ISO and can be readily implemented on most MR systems. The ISO signal is either shifted out of the image by using a narrow acquisition bandwidth, suppressed by using a frequency selective suppression pulse or not excited by using a narrow excitation bandwidth in a 3D acquisition. These methods are tested in mice anaesthetized with ISO and injected with perfluoro-15-crown-5 ether (PFCE) containing nanoparticles (NPs) as the 19F signal of interest. The methods either shift the ISO signal away from the region of interest, suppress the ISO signal or avoid exciting the ISO altogether.
Theory
In image formation in MRI, the MR signal can be spatially localized during excitation with slice or slab selection and during signal reception by a combination of phase and frequency encoding. Whenever magnetic field gradients are used for slice-selective excitation or for spatial encoding during signal reception, chemical shift displacement artifacts (CSDA) occur when signals are present at multiple resonance frequencies. During slices selection, the signal of interest, at the scanner’s reference or carrier frequency, is excited or refocused at the slice position of choice. Off-resonant signals (ISO in our case) experience this excitation or refocusing at a displaced slice position, of which the distance from the intended position depends on the frequency difference from the off-resonant signal to the carrier frequency and the bandwidth of the selective radiofrequency pulse. During signal reception, the signal of interest is projected in its real location in the image, but all off-resonance signals experience a chemical-shift dependent displacement in the image along the frequency encoding direction. With its wide chemical shift range of resonances, different signals in 19F MRI can be largely displaced relative to each other in excitation and reception. In our 19F MRI example, three resonance groups are present (PFCE singlet at − 91.5 ppm, ISO CF3-group singlet at − 82.9 ppm and J-coupled ISO CF2-group of peaks at − 89.9 ppm, Fig. 2A). When a PFCE and ISO phantom is imaged with a standard pulse sequence with the carrier frequency at − 91.5 ppm, the acquired image contains a PFCE signal in the real location and a displaced signal from the CF3-group of ISO (Fig. 2B). Note that when imaging in vivo, both the CF3 and CF2 groups from ISO are visible and can be present at multiple unexpected locations within the animal. Since the ISO signals have a higher resonance frequency compared to PFCE and, in this example, the frequency encoding direction is from bottom to top, the ISO signals shift upwards. The degree of shift, expressed in pixels, is the direct result of the frequency encoding acquisition bandwidth and the frequency difference between ISO signals and the imaging reference frequency (i.e. the PFCE frequency) and can therefore be defined by:
Similarly, if slice or slab selection is used, and the imaging reference frequency is the PFCE frequency, the CSDA causes a relative shift in slice excitation position of ISO, which depends on the bandwidth of the excitation radiofrequency pulse of:
In this work, we use the known frequency differences between a PFCE-containing imaging agent and ISO signals (i.e., CF3 offset 4042 Hz and CF2 offset 2820 Hz from PFCE at 11.7 T), and the predictable CSDA, to avoid ISO interference.
Materials and methods
Standard MRI methods
All imaging was done on an 11.7 T BioSpec Avance III small animal MR system (Bruker BioSpin, Ettlingen, Germany). A dual tuned 19F/1H birdcage body coil (Bruker BioSpin, Ettlingen, Germany) was used for all 1H and 19F data acquisitions. Before recording the 19F MRI images, a 1H MRI image was acquired to optimize scan settings such as shim, water reference frequency and reference radiofrequency (RF) power which were also used for fluorine imaging. The calibration of the power for RF pulses at the 19F frequency has a fixed ratio of 0.85 to the calibrated 1H RF power. Optimized once, and as both frequencies use the same coil, this ratio is always used in this measurement setup.
Phantom imaging
19F MRI on a 1:1 pure PFCE: pure ISO mixture in a test tube was used to illustrate and optimize the ISO avoidance strategies. 19F NMR was performed using a pulse-acquire sequence with parameters: bandwidth = 30 ppm, 8000 points, TR = 3000 ms, 8 averages and a scan time of 24 s. Standard 19F MRI images were acquired with a 2D Rapid Acquisition with Relaxation Enhancement (RARE) sequence with TR = 5000 ms, TE = 15.2 ms, echo train length (ETL) 16, echo spacing 15.2 ms, matrix size = 64 × 64, field of view (FOV) = 32 × 32 mm, number of slices = 5, slice thickness = 1 mm, central frequency = − 91.6 ppm from the base 19F frequency of 470.7858 MHz, excitation bandwidth of 4 kHz with an approximated Hermite shaped pulse, acquisition bandwidth = 391 Hz/pixel, 1 average and a scan time of 20 s. A centric phase-encoding scheme was used to increase image contrast. This pulse is the default pulse for Bruker systems and often designated as a “calculated” pulse.
In vivo imaging
In vivo imaging was done on 10–14-week-old C57Bl/6 female mice (n = 9) intravenously injected with 20 mg PFCE containing poly(lactic-co-glycolic acid) (PLGA)-NPs as described before [18, 19]. The nanoparticles had a diameter of 190 ± 31 nm, a polydispersity index below 0.2 and contained 30 ± 8 wt.% PFCE. The animals were anaesthetized using inhalation anesthesia with ISO in O2: medical air in a ratio 1:2 at 4% induction and 1.5–2% maintenance guided on respiratory rate. All applicable institutional and national guidelines for the care and use of animals were followed (permit: AVD1030020173444). The 1H anatomical reference image was acquired with a respiratory gated 2D FLASH with TR = respiratory cycle (~ 800 ms), TE = 6 ms, flip angle = 80°. Subsequently, a 19F NMR spectrum was acquired using equal parameters to the phantom experiment. 19F MRI was acquired with a 2D-RARE pulse sequence with parameters as outlined in Table 1. This 2D-RARE sequence was considered the standard 19F sequence and all ISO avoidance strategies were variants of this standard sequence. We used a RARE sequence as it benefits most from the very long T2 of PFCE which enables long echo trains and does not suffer from banding artifacts that often occur with e.g. a balanced steady state free precession (bSSFP) sequence at 11.7 T.
Methods to avoid ISO
The difference in resonance frequencies of the main peak of ISO and PFCE is 11.4 ppm, which corresponds to 4042 Hz at 11.7 T. Here, we investigate three different methods to avoid the CSDA of ISO, which can all be implemented using conventional imaging sequences on most pre-clinical imaging systems: (1) Out of plane shift by using a narrow acquisition bandwidth: We use the chemical shift difference between ISO and the imaging agent in the frequency direction to shift the ISO signal away from the region of interest; (2) Suppress the ISO signal before acquisition using a frequency selective suppression pulse; (3) Narrow excitation to prevent excitation of any ISO within the coil.
Out of plane shift
In order to shift the ISO signal out of plane, we can increase the pixel shift, by decreasing the acquisition bandwidth, until the ISO signal projects outside of the region of interest (Fig. 3) [20]. This approach is feasible because of the very wide range of resonance frequencies in 19F MRI and the relatively big frequency difference between ISO and PFCE. An acquisition bandwidth of 78 Hz/pixel was used; see Table 1 for the other imaging parameters. Note the long TR, the result of a longer TE, needed for signal acquisition with a narrow acquisition bandwidth, which totals to a very long echo train duration.
ISO suppression
A frequency-selective 90°-suppression pulse without a spoiler is applied on the known ISO frequencies just before excitation of the PFCE signal (Fig. 4C). See Table 1 for the exact imaging parameters. The success of this approach depends on a good shim, homogeneous B1 field and an optimal trade-off between pulse duration and pulse profile. Longer suppression pulses are more selective but increase the repetition time. Increasing the TR implies reduction of the number of averages to keep the total acquisition time the same, decreasing the resulting signal to noise ratio (SNR). Four suppression pulses were compared to reach the optimal trade-off between pulse duration and suppression profile (Fig. 4D). To cover a large range of spectral suppression, we chose a suppression bandwidth of 5.5 kHz. Pulses used were a Gaussian pulse (Gauss), a 3 lobe sinc pulse (sin3), a 7 lobe sinc pulse with Hamming window (sin7H) and a hyperbolic-secant pulse (secH). The offset frequency was optimized in a range that was between 4 and 8.1 ppm offset frequency, resulting in an optimum at an offset from the excitation frequency of 3681 Hz.
Narrow excitation
Similar to a spatial encoding gradient applied during signal readout, a gradient is applied during slice selection. This means that a CSDA also occurs in the slice direction, although often less visible due to much larger excitation bandwidth/slice compared to acquisition bandwidth/pixel. Again, we can use the off-set resonance frequency of ISO to our advantage by shifting the ISO excitation slice outside the coil or animal, as shown in Fig. 5D. When using a 2D sequence, this would result in excessively small excitation bandwidths or very thick slices. Therefore, this strategy is only feasible when employing a 3D sequence that excites an entire image volume, in essence creating one very thick slice, and subsequently perform localization in the slice direction with additional phase encoding (Fig. 5). See Table 1 for the exact imaging parameters used here.
Quantification of ISO suppression and image quality
All quantification was done on 3 animals unless specified otherwise in the figures. ISO suppression was quantified as the ratio of the magnitude of the ISO-signal to the magnitude of the noise floor signal, as shown in Fig. 1C (ISO-noise floor-ratio). Using the ISO SNR (Fig. 1B) would be inaccurate because the ill-defined ISO signal does not allow repeatable measurements with certainty. Because the ISO signal is shifted upwards, the noise floor was taken from a region at the bottom of the image. Complete suppression of ISO will result in an ISO-noise floor-ratio of 1. SNR is defined here as the mean magnitude signal divided by the standard deviation of the noise.
Statistical methods
Relative SNR and ISO signal data are reported as mean and standard deviation of 3 animals per strategy unless specified otherwise. For statistical analysis, a one-way two-sided ANOVA was used. A p value of < 0.05 was considered statistically significant.
Results
Conventional images with the standard sequence
The in vivo 19F NMR spectrum of an ISO-anaesthetized mouse injected with PFCE-NPs and the in vitro 19F NMR spectrum of the PFCE:ISO phantom can be used to measure the frequency, magnitude and frequency difference of ISO and PFCE (Fig. 2A). ISO contains a CF3 group that is observed as a singlet at 82.9 ppm and a CF2 group that shows J-coupling at 89.9 ppm (Fig. 2A). The difference between PFCE and ISO in the phantom is 8.6 ppm or 4042 Hz and 1.6 ppm or 752 Hz at 11.7 T for the CF3 and CF2 peaks, respectively. The ISO CF3 group is shifted 10 pixels up in the frequency direction when scanning with an acquisition bandwidth of 391 Hz/pixel.
The in vivo spectrum shows broader PFCE and ISO peaks that are also shifted relative to each other when compared to the in vitro spectrum (Fig. 2C). The transversal in vivo images at the level of the mouse liver show the PFCE-NP signal in the various liver lobes and the bone marrow of the spine as reported previously (Fig. 2D) [19]. The off-resonance ISO signal results in CSDA. The ISO CSDA is visible as ill-defined bands that are shifted upward from the subcutaneous fat tissue of the mouse (ISO-noise floor-ratio = 1.90 ± 0.46) (Fig. 2D, E, F). The ISO signal has a SNR comparable to that of PFCE with a SNR of 10.2 vs. 8.3 for PFCE and ISO respectively (Fig. 2D, E, F).
Out-of-plane-shift by using a narrow acquisition bandwidth
When using a pixel bandwidth of 78 Hz/pixel the ISO signal is barely visible in the image and does no longer project on top of the PFCE signal (ISO-noise floor-ratio = 1.11 ± 0.01) (Fig. 3B). ISO signals at frequencies out of the acquisition bandwidth are very efficiently filtered out with digital filtering. Therefore, interpretation and quantification of the PFCE signal is no longer impeded by the ISO CSDA. Figure 3A illustrates the relationship between Δf (Hz) and acquisition bandwidth (Hz/pixel). Figure 3C visualizes how a change in acquisition bandwidth influences the pixel shift of the off-resonance ISO.
Suppress the ISO signal before acquisition
Selective suppression of either the ISO or PFCE signal is feasible, both in the phantom tube as well as in vivo (ISO-noise floor-ratio = 1.09 ± 0.10) (Fig. 4A and B). A simple Gaussian suppression pulse is very short but yields suboptimal ISO suppression and even suppresses part of the PFCE signal (Fig. 4D). All other pulses successfully suppress the ISO signal. All pulse shapes result in off-target suppression of the PFCE signal. The hyperbolic secant (SecH) pulse shows the least suppression of PFCE (relative SNR 96 ± 1%) (Fig. 4D).
Narrow excitation
The on-resonance 32 mm PFCE slab is located in the planned location, whereas the off-resonance ISO slab is shifted due to the CSDA (Fig. 5D). With a 1-kHz excitation bandwidth the relative shift in slab position of the J-coupled ISO resonance (at 2820 Hz) is 282%, according to Eq. (2). The ISO excitation position is shifted 2.8 slab thicknesses, corresponding to ~ 90 mm and is therefore out of the sensitive area of the RF coil, so it is neither excited, nor observed when using a 1-kHz excitation bandwidth of a 3D slab (ISO-noise floor-ratio = 1.03 ± 0.02) (Fig. 5A).
Comparison of image sequences
With the presented strategies, PFCE can be successfully visualized without interfering ISO signals (Fig. 6A). Successful ISO avoidance is apparent in all three strategies when compared to the standard sequence which suffers from ISO CSDA (Fig. 6C). The out-of-plane-shift and suppression pulse sequence show no significant change in SNR (p = 0.99, p = 0.95 respectively), the 3D sequence shows a significant increase in SNR compared to the standard sequence (Fig. 6B).
Discussion
19F MRI always involves the introduction of an imaging agent, as there is no visible fluorine present in biological systems. Non-ambiguous and quantitative imaging is the goal with 19F MRI; however, unwanted fluorine signals coming from ISO are often a complicating factor. Various fluorinated molecules are being used as imaging agents for 19F MRI. For some fluorinated molecules, it can be expected that ISO CSDA is not an issue because of the large frequency difference between these molecules and ISO (e.g., perfluorocyclohexane and oxycyte [21, 22]). However, the most commonly used agents (e.g., PFPE, PFOB, PFCE, PERFECTA) are expected to suffer from interfering ISO signals due to their resonance frequencies which are close to that of ISO [18, 23].
Currently, most studies using in vivo 19F MRI do not go into detail on whether and how ISO CSDA are avoided. Often insufficient measures are taken to avoid ISO artifacts: (1) Scanning early in the anesthesia period, with less ISO accumulation and therefore slightly lower signal. (2) High imaging agent signal. (3) Different visibility of ISO through different relaxation times at different magnetic field strengths [24]. Regardless, ISO signal is present and could therefore hamper image interpretation and quantification.
In literature, a number of approaches have been used to avoid ISO artifacts. However, implementation of these strategies might not be straightforward or additional post-processing is needed. For example, chemical shift encoding approaches use a multi-echo acquisition and a modeled image reconstruction to remove CSDA from the image [25, 26]. This approach can reduce SNR in single resonance PFCs and needs implementation of a novel sequence and post-processing. Deconvolution methods use an algorithm-based process to correct for the distortion caused by the known CSDA in post-processing [27, 28]. This technique, however, suffers from blurring, increased noise in low SNR images and artifacts that could impede image interpretation and quantification, especially in the complex and broad CSDA encountered with ISO. Finally, some studies have used injection anesthesia as an alternative to ISO, consequently missing out on the key benefits of using ISO compared to injection anesthesia [8, 29,30,31].
In this work, three distinct strategies to avoid ISO CSDA are described, all of which can be applied in 19F MRI without a special sequence or post-processing (Table 2). These methods rely on the differences in resonance frequencies between ISO and the imaging agent. The illustrated explanations in this work help understand the ratio behind these strategies. Overall, these strategies will image only one resonance frequency resulting in SNR loss in multiple-resonance PFCs such as PFOB. The methods need to be adapted to the user’s magnetic field strength, fluorine molecule, object size and resolution depending on the specific situation of the user [32]. The influence of magnetic field strength on the applicability of the strategies to avoid ISO artifacts is not investigated here. At lower field strength, the frequency difference between the signal of interest and the ISO signal will be smaller. As result, the bandwidth needed to achieve the same effect also needs to be smaller. This will be challenging for the shift out of plane sequence, but is very well feasible for the two other strategies.
Compared to the phantom NMR spectrum of Fig. 2A, in vivo line broadening of PFCE is observed (Fig. 2C). This line broadening can be the result of inferior shimming and/or PFCE molecular mobility differences in vivo compared to a simple phantom tube. For ISO, not only line broadening, but also a different in vivo chemical shift is observed (Fig. 2A, C). This is the result of binding and dissolving of ISO in lipids, changing its molecular mobility and chemical environment [24].
Shifting the ISO signal out of the image, by using a narrow acquisition bandwidth, successfully removes the ISO artifact from the image. This approach has downsides. Signal might be lost due to a longer TE, and increased blur may occur due to signal decay during the frequency readout. Signal loss is in part negated by lower noise due to the low acquisition bandwidth, but blurring of the image occurs because the acquisition bandwidth per pixel is smaller than the peak width of PFCE in vivo. These artifacts are clearly visible in Fig. 3B, where the PFCE signal can be seen projecting outside of the animal.
Suppressing the ISO signal by using a frequency selective suppression pulse resulted in complete ISO signal suppression. If this approach fails, possible reasons could be the quality of the shim or B1 field inhomogeneities greater than the chemical shift differences. It might be possible to improve the robustness of the suppression pulse approach by using a suppression pulse flip angle slightly larger than 90° to compensate for the recovery of signal between the suppression pulse and excitation pulse (in our case 3 ms). Moreover, the addition of the suppression pulse leads to an increase in SAR which can result in heating of the subject.
The do-not-excite sequence, using a 3D acquisition scheme has two major advantages. First, an increase in SNR (151 ± 28%) due to the 3D approach. Second, applicability at lower magnetic field strength as the excitation bandwidth can easily be further decreased. In the do-not-excite-ISO sequence, the aim is to use the slab-selective magnetic field gradient to temporarily have the off-resonant ISO signal resonate at frequencies out of reach with the applied RF pulse outside of the coil with an appropriate combination of pulse bandwidth and chemical shift difference, as illustrated in Fig. 5D. When the ISO signal resonance frequencies are moved outside of the RF coil sensitivity profile, they will not be excited and cannot produce a signal during acquisition. By defining a relative — rather than absolute — shift in slice or slab position as we do in Eq. (2), the shift description is independent of the applied magnetic field strength, but expressed in a factor or percentage relative to the intended slice or slab thickness. With known RF pulse bandwidth, the applied magnetic field gradient defines the slice or slab thickness, and the relative shift defines the position of the off-resonant excitation. In our example, a 32-mm slab is used. With a 1-kHz excitation bandwidth and a chemical shift difference of 2820 Hz, this means that the center of the excitation slab at the ISO-frequency is located 2.82 slabs, or 90 mm, away from the location of the on-resonance PFCE. With a 40-mm coil length ISO, signal frequencies are beyond the coil’s excitation profile. This method has been used successfully previously [19, 33, 34]. If a coil setup is used in which transmit and receive coils are separated, usually the transmit RF coil is larger than the local receive coil. In such cases ISO signals can still be excited, but perhaps not received with the local receive coil.
In summary, we recommend to report on the method used to avoid ISO CSDA in all 19F studies that use ISO as anesthetic. In order to understand how ISO CSDA are avoided, the method section should include the following parameters: Frequency difference between the fluorinated molecule of interest and ISO, excitation and acquisition bandwidth and pulse shape, 2D or 3D sequence and coil length. When using a suppression pulse the bandwidth, offset, flip angle and shape of this pulse should be provided.
Conclusions
In this study, we show that anesthetic levels of ISO result in unwanted and complex CSDA in 19F MRI. These artifacts negate two of the favorable characteristics of 19F MRI: non-ambiguous image interpretation and quantification. We optimized three easily implementable methods to avoid ISO signals and show their performance in vitro and in vivo. The 3D narrow excitation strategy yielded the best results by completely avoiding ISO imaging and improving SNR. We recommend to routinely report on which method, if any, is used to prevent ISO artifacts in pre-clinical 19F MRI studies.
References
Ruiz-Cabello J, Barnett BP, Bottomley PA, Bulte JWM (2011) Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed 24:114–129. https://doi.org/10.1002/nbm.1570
Chen J, Lanza GM, Wickline SA (2010) Quantitative magnetic resonance fluorine imaging: today and tomorrow. Wiley Interdiscip Rev Nanomedicine Nanobiotechnol 2:431–440. https://doi.org/10.1002/wnan.87
Tirotta I, Dichiarante V, Pigliacelli C et al (2015) 19 F Magnetic resonance imaging (MRI): from design of materials to clinical applications. Chem Rev 115:1106–1129. https://doi.org/10.1021/cr500286d
Srinivas M, Heerschap A, Ahrens ET et al (2010) (19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol 28:363–370. https://doi.org/10.1016/j.tibtech.2010.04.002
Srinivas M, Morel PA, Ernst LA et al (2007) Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 58:725–734. https://doi.org/10.1002/mrm.21352
Colombo M, Carregal-Romero S, Casula MF et al (2012) Biological applications of magnetic nanoparticles. Chem Soc Rev 41:4306. https://doi.org/10.1039/c2cs15337h
Liu Y, Zhang N (2012) Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging. Biomaterials 33:5363–5375. https://doi.org/10.1016/j.biomaterials.2012.03.084
Srinivas M, Turner MS, Janjic JM et al (2009) In vivo cytometry of antigen-specific t cells using 19 F MRI. Magn Reson Med 62:747–753. https://doi.org/10.1002/mrm.22063
Ahrens ET, Bulte JW (2013) Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 13:755–763. https://doi.org/10.1038/nri3531
Flogel U, Ding Z, Hardung H et al (2008) In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118:140–148. https://doi.org/10.1161/CIRCULATIONAHA.107.737890
Zhong J, Narsinh K, Morel PA et al (2015) In vivo quantification of inflammation in experimental autoimmune encephalomyelitis rats using Fluorine-19 Magnetic Resonance Imaging reveals immune cell recruitment outside the nervous system. PLoS ONE 10:e0140238. https://doi.org/10.1371/journal.pone.0140238
Wüst RCI, Calcagno C, Daal MRR et al (2019) Emerging magnetic resonance imaging techniques for atherosclerosis imaging. Arterioscler Thromb Vasc Biol 39:841–849. https://doi.org/10.1161/ATVBAHA.118.311756
Hoogendijk E, Swider E, Staal AHJ, et al (2020) Continuous-flow production of perfluorocarbon-loaded polymeric nanoparticles: from the bench to clinic. ACS Appl Mater Interfaces acsami.0c12020. https://doi.org/10.1021/acsami.0c12020
Ahrens ET, Helfer BM, O’Hanlon CF, Schirda C (2014) Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med 72:1696–1701. https://doi.org/10.1002/mrm.25454
Litt L, Lochhart S, Cohen Y et al (1991) In vivo 19 F Nuclear Magnetic Resonance brain studies of halothane, isoflurane, and desflurane. Ann N Y Acad Sci 625:707–724. https://doi.org/10.1111/j.1749-6632.1991.tb33904.x
Ludders JW (1992) Advantages and guidelines for using isoflurane. Vet Clin North Am Small Anim Pract 22:328–331. https://doi.org/10.1016/S0195-5616(92)50626-X
Kober F, Iltis I, Cozzone PJ, Bernard M (2004) Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/xylazine and isoflurane. Magn Reson Mater Physics, Biol Med 17:157–161. https://doi.org/10.1007/s10334-004-0086-0
Srinivas M, Cruz LJ, Bonetto F et al (2010) Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials 31:7070–7077. https://doi.org/10.1016/j.biomaterials.2010.05.069
Staal AHJ, Becker K, Tagit O et al (2020) In vivo clearance of 19F MRI imaging nanocarriers is strongly influenced by nanoparticle ultrastructure. Biomaterials 261:120307. https://doi.org/10.1016/j.biomaterials.2020.120307
Steinseifer IK, Wijnen JP, Hamans BC et al (2013) Metabolic imaging of multiple X-nucleus resonances. Magn Reson Med 70:169–175. https://doi.org/10.1002/mrm.24456
Gash VW, Bauer DJ (1966) Some characteristics of the Fluorine Nuclear Magnetic Resonance of alicyclic fluorocarbons. J Org Chem 31:3602–3607. https://doi.org/10.1021/jo01349a031
Darçot E, Colotti R, Brennan D et al (2020) A characterization of ABL‐101 as a potential tracer for clinical fluorine‐19 MRI. NMR Biomed 33: https://doi.org/10.1002/nbm.4212
Akazawa K, Sugihara F, Nakamura T et al (2018) Perfluorocarbon-based 19 F MRI nanoprobes for in vivo multicolor imaging. Angew Chemie Int Ed 57:16742–16747. https://doi.org/10.1002/anie.201810363
Constantinides C, Maguire ML, Stork L et al (2017) Temporal accumulation and localization of isoflurane in the C57BL/6 mouse and assessment of its potential contamination in 19 F MRI with perfluoro-crown-ether-labeled cardiac progenitor cells at 9.4 Tesla. J Magn Reson Imaging 45:1659–1667. https://doi.org/10.1002/jmri.25564
van Heeswijk RB, Colotti R, Darçot E et al (2018) Chemical shift encoding (CSE) for sensitive fluorine-19 MRI of perfluorocarbons with complex spectra. Magn Reson Med 79:2724–2730. https://doi.org/10.1002/mrm.26895
Ludwig KD, Hernando D, Roberts NT et al (2018) A chemical shift encoding (CSE) approach for spectral selection in fluorine-19 MRI. Magn Reson Med 79:2183–2189. https://doi.org/10.1002/mrm.26874
Meissner M, Reisert M, Hugger T et al (2015) Revealing signal from noisy 19 F MR images by chemical shift artifact correction. Magn Reson Med 73:2225–2233. https://doi.org/10.1002/mrm.25370
Lee HK, Nalcioglu O (1992) Reblurred deconvolution method for chemical shift removal in F-19 (PFOB) MR imaging. J Magn Reson Imaging 2:53–61. https://doi.org/10.1002/jmri.1880020110
Ribot E, Gaudet J, Chen Y et al (2014) In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence. Int J Nanomedicine 1731. https://doi.org/10.2147/IJN.S59127
el-Tahtawy A, Wolf W (1991) In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy. Cancer Res 51:5806–12
Srinivas M, Boehm-Sturm P, Aswendt M et al (2013) In vivo 19F MRI for cell tracking. J Vis Exp e50802. https://doi.org/10.3791/50802
Peeters TH, Kobus T, Breukels V et al (2019) Imaging hyperpolarized pyruvate and lactate after blood-brain barrier disruption with focused ultrasound. ACS Chem Neurosci 10:2591–2601. https://doi.org/10.1021/acschemneuro.9b00085
Gaudet JM, Ribot EJ, Chen Y et al (2015) Tracking the fate of stem cell implants with Fluorine-19 MRI. PLoS ONE 10:e0118544. https://doi.org/10.1371/journal.pone.0118544
Makela AV, Foster PJ (2018) Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine-19 MRI cell tracking. Magn Reson Med 80:1138–1147. https://doi.org/10.1002/mrm.27081
Acknowledgements
We would like to thank Koen van Riessen, Kitty Lemmens-Hermans, Bianca Lemmers-van de Weem and Karin de Haas-Cremers for their excellent technical support. This work was funded by an ERC starting grant (ERC-2014-StG-336454-CoNQUeST), TTW-NWO open technology grant (STW-14716) and ERA-CVD grant (JTC2017-044).
Author information
Authors and Affiliations
Contributions
A.H.J.S. Conceptualization, methodology, formal analysis, investigation, writing original draft, visualization. A.V. Methodology, investigation, writing review and editing, recourses. M.S. Writing review and editing, supervision, funding acquisition. T.W.J.S. Conceptualization, recourses, supervision, writing review and editing.
Corresponding author
Ethics declarations
Conflict of interest
M.S. is CSO of Cenya Imaging b.v.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Staal, A.H.J., Veltien, A., Srinivas, M. et al. 19F MRI Imaging Strategies to Reduce Isoflurane Artifacts in In Vivo Images. Mol Imaging Biol 24, 71–81 (2022). https://doi.org/10.1007/s11307-021-01653-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-021-01653-6